Physician profile
Luis Marrero Abascal
NPI 1326209073
$623.87
in general payments reported to CMS, 2019-2025
11 companies · $26.41 in 2025
The $26.41 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $105 · 2021: $169 · 2022: $65.09 · 2023: $42.24 · 2024: $19.74 · 2025: $26.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $107.57 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $98.42 | 2019-2021 | |
| Glaxosmithkline, LLC. | $83.88 | 2020-2021 | |
| Abbvie INC. | $61.82 | 2021-2024 | |
| Evoke Pharma, INC. | $60.81 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.53 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.47 | 2019 | |
| Vanda Pharmaceuticals INC. | $46.17 | 2022 | |
| Corcept Therapeutics | $26.41 | 2025 | Korlym |
| Lilly USA, LLC | $18.92 | 2022 | |
| Apria Healthcare LLC | $17.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Marrero Abascal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.